Baxter International Inc. [BAX] fell -23.08% so far this year. What now?



Baxter International Inc. [NYSE: BAX] gained 0.67% on the last trading session, reaching $66.03 price per share at the time. The company report on July 20, 2022 that BAXTER HEALTHCARE ANNOUNCES STEVEN FLYNN TO LEAD ASIA PACIFIC REGION.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Baxter International, a global medtech leader, has announced the appointment of Steven (Steve) Flynn to Senior Vice President and President Baxter Asia Pacific.

Mr Flynn, who has served as General Manager of Baxter Australia and New Zealand since 2015, will lead the Asia Pacific region, reporting directly to Baxter International Chairman, President and Chief Executive Officer, José (Joe) E. Almeida.

Baxter International Inc. represents 503.00 million in outstanding shares, while the company has a total market value of $32.48 billion with the latest information. BAX stock price has been found in the range of $65.475 to $66.59.

If compared to the average trading volume of 2.99M shares, BAX reached a trading volume of 2292518 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Baxter International Inc. [BAX]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BAX shares is $85.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BAX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for Baxter International Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on June 24, 2022. While these analysts kept the previous recommendation, Goldman dropped their target price from $88 to $77. The new note on the price target was released on April 04, 2022, representing the official price target for Baxter International Inc. stock. Previously, the target price had yet another raise to $100, while BofA Securities analysts kept a Buy rating on BAX stock. On February 18, 2022, analysts decreased their price target for BAX shares from 95 to 93.

The Average True Range (ATR) for Baxter International Inc. is set at 1.57, with the Price to Sales ratio for BAX stock in the period of the last 12 months amounting to 2.40. The Price to Book ratio for the last quarter was 3.66, with the Price to Cash per share for the same quarter was set at 4.66. Price to Free Cash Flow for BAX in the course of the last twelve months was 40.81 with Quick ratio for the last quarter at 1.40.

Trading performance analysis for BAX stock

Baxter International Inc. [BAX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.12. With this latest performance, BAX shares gained by 3.14% in over the last four-week period, additionally sinking by -22.86% over the last 6 months – not to mention a drop of -17.74% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BAX stock in for the last two-week period is set at 48.45, with the RSI for the last a single of trading hit 55.62, and the three-weeks RSI is set at 44.99 for Baxter International Inc. [BAX]. The present Moving Average for the last 50 days of trading for this stock 69.17, while it was recorded at 65.24 for the last single week of trading, and 77.95 for the last 200 days.

Baxter International Inc. [BAX]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Baxter International Inc. [BAX] shares currently have an operating margin of +16.29 and a Gross Margin at +40.83. Baxter International Inc.’s Net Margin is presently recorded at +10.04.

Return on Equity for this stock inclined to 14.45, with Return on Assets sitting at 4.80.

Baxter International Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 2.10.

Baxter International Inc. [BAX]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BAX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Baxter International Inc. go to 14.05%.

An analysis of insider ownership at Baxter International Inc. [BAX]

There are presently around $28,327 million, or 89.20% of BAX stock, in the hands of institutional investors. The top three institutional holders of BAX stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 55,569,944, which is approximately 11.921% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 39,996,135 shares of the stock with an approximate value of $2.62 billion in BAX stocks shares; and VANGUARD GROUP INC, currently with $2.62 billion in BAX stock with ownership of nearly 2.431% of the company’s market capitalization.

Positions in Baxter International Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 463 institutional holders increased their position in Baxter International Inc. [NYSE:BAX] by around 33,476,517 shares. Additionally, 528 investors decreased positions by around 30,269,222 shares, while 254 investors held positions by with 368,137,547 shares. The mentioned changes placed institutional holdings at 431,883,286 shares, according to the latest SEC report filing. BAX stock had 100 new institutional investments in for a total of 4,486,552 shares, while 117 institutional investors sold positions of 2,352,934 shares during the same period.